Browse articles from EyeWorld.org related to COVID-19. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ ASCRS EyeWorld Weekly: View the current issue
➤ Study: COVID-19 significantly reduced rate of ophthalmic procedures
➤ New device provides non-surgical treatment for lower lid laxity
➤ Autonomous Diabetic Retinopathy Screening offers ‘unparalleled results’
➤ 52-week data from Phase 2b study evaluating wet AMD therapy
➤ Subgroup analysis provides additional data on wet AMD therapy
➤ ASCRS news and events
When a patient is scheduled for LASIK, they have high expectations for that postop day 1 “wow” factor that LASIK provides, said Ella Faktorovich, MD. However, in the years following the onset of the COVID-19 pandemic, Dr. Faktorovich noticed increased frequency of epithelial loosening during LASIK flap lift.
The push for widespread COVID-19 vaccination has renewed the focus on the side effects that vaccines may have. It’s an especially unique situation due to the distinct timeframe for this mass vaccination campaign. Two experts spoke about potential ocular impacts of the vaccine and what physicians should look for.
Practice volumes have returned, and efficiency has been re-established. The most fortunate practices have learned how to operate in a tighter labor market. But not all practices can make these claims. How can your practice finally shake off the lingering business equivalent of “long COVID?” This article presents six areas for consideration.
➤ Two-year results from Phase 3 study for GA therapy
➤ BLA resubmission for bevacizumab
➤ Strategic licensing for pharmacologic treatment for keratoconus
➤ Study: Gene therapy restores some cone function to otherwise colorblind children
➤ ASCRS news and events
➤ 36- and 48-month efficacy demonstrated with canaloplasty
➤ Phase 1/2 trial for gene therapy for X-linked retinitis pigmentosa
➤ Topline results from Phase 2a trial for possible DME therapy
➤ Preclinical data shows potential for gene therapy to address Leber congenital amaurosis
➤ ASCRS news and events
➤ FDA approves device to treat MGD
➤ Standalone MIGS device trial begins
➤ Topline results for novel dry eye candidate
➤ Orphan drug designation granted for topical LHON treatment
➤ Positive safety results in Phase 1/2a trial for investigational treatment of wet AMD
➤ Updates on two investigational RNA therapies
➤ ASCRS news and events
Scott Gottlieb, MD, former FDA commissioner, spoke at the 2021 ASCRS Annual Meeting in July 2021 in Las Vegas, Nevada, giving an overview of the state of the COVID-19 pandemic at the time, providing insight on how the nation got to where it was at that time, and sharing his thoughts on how the country could reduce its risk in the future.
➤ Study: Standalone trabeculotomy/viscodilation 24-month outcomes
➤ Proof of concept for dropless immunosuppression after PK
➤ Topline Phase 2 data for high-dose aflibercept in wet AMD
➤ Companies enter licensing agreement for investigational ophthalmic therapies
➤ ASCRS news and events
The COVID-19 pandemic has had an impact on the screening and use of corneal donor tissue for corneal transplants. Three surgeons spoke about the evolving regulations, tissue eligible for use, and more.
